The British Minister of Health made ominous predictions about the effectiveness of the vaccines against the “South African mutation” of the coronavirus in a “closed” teleconference with travel agents – He thought that his words would not be made public
The South African coronavirus mutation could reduce the effectiveness of vaccines by 50%, said British Health Minister Matt Hancock. In fact, the minister said that if the widespread transmission of this mutation to Britain was allowed, it could destroy the country’s vaccination program.
- Does This Mean We Stopped Being Animal and Started Being Human Due to ‘Copy Paste’ Errors?
- The One Lifestyle Choice That Could Reduce Your Heart Disease Risk By More Than 22%
- Aging: This Is What Happens Inside Your Body Right After Exercise
- Immune-Boosting Drink that Mimics Fasting to Reduce Fat – Scientists ‘Were Surprised’ By New Findings
- Gun Violence in America: What They Don’t Talk About at the Debate
According to the Daily Mail, which released the relevant video, the minister made the relevant reports in a teleconference with travel agents during the week – shocking his audience. However, Hancock made it clear shortly afterwards that this was preliminary information – to add “I would not say this in public“.
The South African mutation has differences in the “protein spike”, leading scientists to fear that the immune system of people who have been vaccinated could not recognize – and fight.
The alarming reports from the British Ministry of Health come after scientists in South Africa found that 48% of blood samples from people who had been infected with the “original” coronavirus and therefore had developed antibodies did not show any reaction to the mutant virus.
It is noted that the “South African mutation” of the virus is considered more contagious than the “British mutation”. In Britain, 73 cases of “South African mutation” have been identified so far – although it is suspected that its transmission may already be much higher, as only 10% of positive samples are tested in laboratories to find out which mutation the virus belongs to.